{"id":"NCT00376168","sponsor":"Pfizer","briefTitle":"A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease","officialTitle":"A Phase III, Multicenter, Randomized, Double-Blind Trial to Assess the Safety and Efficacy of Two Parallel Dose Groups of Plant Cell Expressed Recombinant Human Glucocerebrosidase (prGCD) in Patients With Gaucher Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-08","primaryCompletion":"2009-09","completion":"2009-10","firstPosted":"2006-09-14","resultsPosted":"2012-07-26","lastUpdate":"2018-10-04"},"enrollment":32,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Gaucher Disease"],"interventions":[{"type":"DRUG","name":"Plant cell expressed recombinant glucocerebrosidase (prGCD)","otherNames":["Taliglucerase alfa"]},{"type":"DRUG","name":"Plant cell expressed recombinant glucocerebrosidase (prGCD)","otherNames":["Taliglucerase alfa"]}],"arms":[{"label":"prGCD 30 Units/kg","type":"EXPERIMENTAL"},{"label":"prGCD 60 Units/kg","type":"EXPERIMENTAL"}],"summary":"Gaucher disease, the most prevalent lysosomal storage disorder, is caused by mutations in the human glucocerebrosidase gene (GCD) leading to reduced activity of the lysosomal enzyme glucocerebrosidase and thereby to the accumulation of substrate glucocerebroside (GlcCer) in the cells of the monocyte-macrophage system.\n\nThis is the second trial to utilize a recombinant active form of lysosomal enzyme, glucocerebrosidase, (human prGCD) which is expressed and purified in a bioreactor system from transformed carrot plant root cell line.","primaryOutcome":{"measure":"Change From Baseline in Spleen Volume Measured by MRI.","timeFrame":"Baseline and 9 months","effectByArm":[{"arm":"ELELYSO 30 Units/kg","deltaMin":-26.91,"sd":7.79},{"arm":"ELELYSO 60 Units/kg","deltaMin":-38.01,"sd":9.38}],"pValues":[{"comp":"OG000","p":"<0.0001"},{"comp":"OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":6},"locations":{"siteCount":11,"countries":["United States","Canada","Chile","Israel","Italy","South Africa","Spain","United Kingdom"]},"refs":{"pmids":["26053270","21900191","18729283"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":16},"commonTop":["Hypersensitivity","Headache","Abdominal pain","Feeling hot","Arthralgia"]}}